INR 1.64
(4.46%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 222.75 Million INR | 39.92% |
2022 | 159.2 Million INR | 22.62% |
2021 | 129.83 Million INR | 1.46% |
2020 | 127.96 Million INR | 11.15% |
2019 | 115.12 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -839.89 Million INR | -477.04% |
2024 Q2 | 134.19 Million INR | 115.98% |
2023 Q2 | 142.35 Million INR | 0.0% |
2023 FY | 222.75 Million INR | 39.92% |
2023 Q4 | 222.75 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2022 Q4 | 159.2 Million INR | 0.0% |
2022 Q2 | 126.86 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 727.95 Million INR | 69.4% |
Checkpoint Trends Limited | 4 Million INR | -5458.822% |
Everest Organics Limited | 1.8 Billion INR | 87.685% |
GUJARAT INJECT (KERALA) LTD. | 1.47 Million INR | -15043.236% |
NATURO INDIABULL LIMITED | 537.34 Million INR | 58.545% |
NEXUS SURGICAL AND MEDICARE LI | 12.39 Million INR | -1696.435% |
Rama Vision Limited | 291.78 Million INR | 23.658% |
Vivo Bio Tech Limited | 827.33 Million INR | 73.075% |